Nemifitide diTFA is a synthetic pentapeptide antidepressant with potential for rapid onset of action; it acts as a melanocyte-inhibiting factor (MIF) peptide analog and can cross the blood-brain barrier; it and its active metabolite (M1) bind at micromolar concentrations to several receptors, including 5-HT2A, 5-HT2C, melanocortin MC4, MC5, and bombesin receptors; in vivo, it significantly increases swimming behavior in Flinders Sensitive Line (FSL) rats—a model of depression—after only 5 days of treatment (0.3 mg/kg, i.p., daily for 14 days), demonstrating long-lasting antidepressant effects; it shows significant efficacy at both low (0.025–0.3 mg/kg) and high (3.0–15.0 mg/kg) doses, but not at intermediate doses (0.4–2.4 mg/kg).